Management of Non-melanoma Skin Cancer

Rogers, 2010, Incidence estimate of nonmelanoma skin cancer in the United States, 2006, Arch Dermatol, 146, 283, 10.1001/archdermatol.2010.19

American Cancer Society. Cancer Facts & Figures 2013. Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdf (accessed January 31, 2013).

Chen, 2001, Cost of nonmelanoma skin cancer treatment in the United States, Dermatol Surg, 27, 1035, 10.1046/j.1524-4725.2001.01004.x

Cockerell, 2011, Basal cell carcinoma, 101

Karagas, 1992, Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group, JAMA, 267, 3305, 10.1001/jama.1992.03480240067036

Ferrucci, 2012, Host-phenotype characteristics and MC1R in relation to early-onset basal cell carcinoma, J Invest Dermatol, 132, 1272, 10.1038/jid.2011.402

Marghoob, 1993, Risk of another basal cell carcinoma developing after treatment of a basal cell carcinoma, J Am Acad Dermatol, 28, 22, 10.1016/0190-9622(93)70003-C

Alam, 2001, Cutaneous squamous-cell carcinoma, N Engl J Med, 344, 975, 10.1056/NEJM200103293441306

The Skin Cancer Foundation. Squamous cell carcinoma (SCC). Available at: http://www.skincancer.org/skin-cancer-information/squamous-cell-carcinoma (accessed March 15, 2013).

Frankel, 1992, New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin: implications and recommendations for follow-up, J Am Acad Dermatol, 26, 720, 10.1016/0190-9622(92)70100-T

Marcil, 2000, Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis, Arch Dermatol, 136, 1524, 10.1001/archderm.136.12.1524

Silverman, 1992, Recurrence rates of treated basal cell carcinomas. Part 3: surgical excision, J Dermatol Surg Oncol, 18, 471, 10.1111/j.1524-4725.1992.tb03307.x

Rowe, 1992, Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection, J Am Acad Dermatol, 26, 976, 10.1016/0190-9622(92)70144-5

Beebe, 2009, A review of Merkel cell carcinoma for dermatology nurses, J Dermatol Nurs Assoc, 1, 173, 10.1097/JDN.0b013e3181a82094

Miller, 2010, Basal cell and squamous cell skin cancers, J Natl Compr Canc Netw, 8, 836, 10.6004/jnccn.2010.0062

Joseph, 1992, Squamous cell carcinoma of the skin of the trunk and limbs: the incidence of metastases and their outcome, Aust N Z J Surg, 62, 697, 10.1111/j.1445-2197.1992.tb07065.x

Tull, 2008, Nonsurgical treatment modalities for primary cutaneous malignancies, Dermatol Surg, 34, 859, 10.1111/j.1524-4725.2008.34170.x

Love, 2009, Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review, Arch Dermatol, 145, 1431, 10.1001/archdermatol.2009.291

Williams, 2011, Topical treatment of skin cancer, 462

Kokoszka, 2003, Evidence-based review of the use of cryosurgery in treatment of basal cell carcinoma, Dermatol Surg, 29, 566, 10.1046/j.1524-4725.2003.29151b.x

Kuflik, 2004, Cryosurgery for skin cancer: 30-year experience and cure rates, Dermatol Surg, 30, 297, 10.1111/j.1524-4725.2004.30090.x

Thissen, 1999, A systematic review of treatment modalities for primary basal cell carcinomas, Arch Dermatol, 135, 1177, 10.1001/archderm.135.10.1177

Neville, 2007, Management of nonmelanoma skin cancer 2007, Nature, 4, 462

Werlinger, 2002, Recurrence rates of primary nonmelanoma skin cancers treated by surgical excision compared to electrodessication-curettage in a private dermatologic practice, Dermatol Surg, 28, 1138, 10.1046/j.1524-4725.2002.02110.x

Kopf, 1977, Curettage-electrodessication treatment of basal cell carcinomas, Arch Dermatol, 113, 439, 10.1001/archderm.1977.01640040047006

Silverman, 1991, Recurrence rates of treated basal cell carcinomas. Part 2: curettage-electrodessication, J Dermatol Surg Oncol, 17, 720, 10.1111/j.1524-4725.1991.tb03425.x

Rogers, 2009, A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption, J Am Acad Dermatol, 61, 96, 10.1016/j.jaad.2008.07.047

Sheridan, 2000, Curettage, electrosurgery and skin cancer, Australas J Dermatol, 41, 19, 10.1046/j.1440-0960.2000.00383.x

Epstein, 1985, Fluouracil paste treatment of thin basal cell carcinomas, Arch Dermatol, 121, 207, 10.1001/archderm.1985.01660020065019

Gaitanis, 2009, Immunocryosurgery for basal cell carcinoma: Results of a pilot prospective, open-label study of cryosurgery during continued imiquimod application, J Eur Acad Dermatol Venereol, 23, 1427, 10.1111/j.1468-3083.2009.03224.x

Gaitanis, 2011, Cryosurgery is more effective in the treatment of primary, non-superficial basal cell carcinomas when applied during and not prior to a five week imiquimod course: a randomized, prospective, open-label study, Eur J Dermatol, 21, 952, 10.1684/ejd.2011.1524

Neville, 2007, Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage, J Drugs Dermatol, 6, 910

Good, 2011, Intralesional agents in the management of cutaneous malignancy: a review, J Am Acad Dermatol, 64, 413, 10.1016/j.jaad.2009.12.013

Marmur, 2004, A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer, Dermatol Surg, 30, 264, 10.1111/j.1524-4725.2004.30083.x

Werner, 2011, Actinic keratoses and other precursors of keratinocytic cutaneous malignancies, 89

Choudhary, 2011, Lasers in the treatment of nonmelanoma skin cancer, Dermatol Surg, 37, 409, 10.1111/j.1524-4725.2011.01928.x

Ibrahim, 2011, Surgical excision for non-melanoma skin cancer, 508

Gulleth, 2010, What is the best surgical margin for a basal cell carcinoma: a meta-analysis of the literature, Plast Reconstr Surg, 126, 1222, 10.1097/PRS.0b013e3181ea450d

Zwald, 2011, Skin cancer in solid organ transplant recipients: advances in therapy and management, J Am Acad Dermatol, 65, 253, 10.1016/j.jaad.2010.11.062

Schadt, 2011, Genetic disorders predisposing to skin malignancy, 357

Rowe, 1989, Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma, J Dermatol Surg Oncol, 15, 424, 10.1111/j.1524-4725.1989.tb03249.x

Spencer, 2010, Basal cell carcinoma

von Domarus, 1984, Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature, J Am Acad Dermatol, 10, 1043, 10.1016/S0190-9622(84)80334-5

Snow, 1994, Metastatic basal cell carcinoma. Report of five cases, Cancer, 73, 328, 10.1002/1097-0142(19940115)73:2<328::AID-CNCR2820730216>3.0.CO;2-U

Walling, 2004, Aggressive basal cell carcinoma: presentation, pathogenesis and management, Cancer Metastasis Rev, 23, 389, 10.1023/B:CANC.0000031775.04618.30

Ladaro, 2010, Improvements in the staging of cutaneous squamous-cell carcinoma in the 7th Edition of the AJCC Cancer Staging Manual, Ann Surg Oncol, 17, 1979, 10.1245/s10434-010-1009-0

Farasat, 2011, A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics, J Am Acad Dermatol, 64, 1051, 10.1016/j.jaad.2010.08.033

Bhambri, 2011, Squamous cell carcinoma, 124

Wisgerhof, 2010, Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors, Transplantation, 89, 1231, 10.1097/TP.0b013e3181d84cdc

Moloney, 2006, A population-based study of skin cancer incidence and prevalence in renal transplant recipients, Br J Dermatol, 154, 498, 10.1111/j.1365-2133.2005.07021.x

Lazareth, 2010, Dermatologic care of the transplant patient; Part I, J Dermatol Nurs Assoc, 2, 59, 10.1097/JDN.0b013e3181d59d5d

Lindelof, 2000, Incidence of skin cancer in 5356 patients following organ transplantation, Br J Dermatol, 143, 513

Lazareth, 2010, Dermatologic care of the transplant patient; Part II, J Dermatol Nurs Assoc, 2, 198, 10.1097/JDN.0b013e3181f5118a

Clayman, 2005, Mortality risk from squamous cell skin cancer, J Clin Oncol, 23, 759, 10.1200/JCO.2005.02.155

Euvrard, 1997, Skin cancers in organ transplant recipients, Ann Transplant, 2, 28

Veness, 2005, Treatment recommendations in patients diagnosed with high-risk cutaneous squamous cell carcinoma, Australas Radiol, 49, 365, 10.1111/j.1440-1673.2005.01496.x

Bowles, 2011, Sarcomas of the skin, 157

Burns, 1994, Microcystic adnexal carcinoma: ten cases treated by Mohs micrographic surgery, J Derm Surg Oncol, 20, 429, 10.1111/j.1524-4725.1994.tb03212.x

Cooper, 1984, Microcystic adnexal carcinoma, J Am Acad Dermatol, 10, 908, 10.1016/S0190-9622(84)80445-4

Chiller, 2000, Microcystic adnexal carcinoma: 48 cases, their treatment and their outcome, Arch Dermatol, 136, 1355, 10.1001/archderm.136.11.1355

Gollard, 2000, Merkel cell carcinoma: review of 22 cases with surgical, pathologic and therapeutic considerations, Cancer, 88, 1842, 10.1002/(SICI)1097-0142(20000415)88:8<1842::AID-CNCR13>3.0.CO;2-P

Young, 2007, Cancer of rare sites, 251

Agelli, 2003, Epidemiology of primary Merkel cell carcinoma in the United States, J Am Acad Dermatol, 49, 832, 10.1016/S0190-9622(03)02108-X

Ratz, 1986, Sebaceous carcinoma of the eyelid treated with Mohs surgery, J Am Acad Dermatol, 14, 668, 10.1016/S0190-9622(86)70084-4

Rowe, 1989, Long term recurrence rates in previously untreated (primary) basal cell carcinoma: Implications for patient follow-up, J Dermatol Surg Oncol, 15, 315, 10.1111/j.1524-4725.1989.tb03166.x

Mosterd, 2008, Surgical excision versus Mohs micrographic surgery for primary and recurrent basal cell carcinoma of the face: a prospective, randomized controlled trial with 5 years follow-up, Lancet Oncol, 9, 1149, 10.1016/S1470-2045(08)70260-2

Upjohn, 2011, Mohs surgery, 515

Nguyen, 2002, Nonmelanoma skin cancer, Curr Treat Options Oncol, 3, 193, 10.1007/s11864-002-0009-0

2012, J Am Acad Dermatol, 67, 531, 10.1016/j.jaad.2012.06.009

Brett, 2012, Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients, J Am Acad Dermatol, 67, 1235, 10.1016/j.jaad.2012.06.001

Cooper, 2011, Radiation therapy in the treatment of skin cancers, 576

Alam, 2011, The use of brachytherapy in the treatment of nonmelanoma skin cancer: a review, J Am Acad Dermatol, 65, 377, 10.1016/j.jaad.2010.03.027

Veness, 2003, Role of modern radiotherapy in treating skin cancer, Aust J Dermatol, 44, 159, 10.1046/j.1440-0960.2003.06711.x

Caccialanza, 1999, Results and side effects of dermatologic radiotherapy: a retrospective study of irradiated cutaneous epithelial neoplasm, J Am Acad Dermatol, 41, 589

Karagas, 1996, Risk of basal cell and squamous skin cancers after ionizing radiation therapy. For the Skin Cancer Prevention Study Group, J Natl Cancer Inst, 88, 1848, 10.1093/jnci/88.24.1848

Veness, 2007, Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers, Aust Radiol, 51, 12, 10.1111/j.1440-1673.2006.01649.x

Wang, 2012, Predictors of outcomes in patients with cutaneous metastatic head and neck squamous cell carcinoma involving cervical lymph nodes: improved survival with the addition of adjuvant radiotherapy, Head Neck, 34, 1524, 10.1002/hed.21965

Loescher, 2011, A systematic review of advanced practice nurses’ skin cancer assessment barriers, skin lesion recognition skills, and skin cancer training activities, J Am Acad Nurs Pract, xx, 667, 10.1111/j.1745-7599.2011.00659.x

Chen, 2004, Variation in care for nonmelanoma skin cancer in a private practice and a veterans affairs clinic, Medical Care, 42, 1019, 10.1097/00005650-200410000-00011

Moody, 1999, Client characteristics and practice patterns of nurse practitioners and physicians, Nurse Pract, 24, 94, 10.1097/00006205-199903000-00007

Cole, 2003, Procedures taught in family nurse practitioner programs in the United States, J Am Acad Nurs Pract, 15, 40, 10.1111/j.1745-7599.2003.tb00253.x

Viola, 2011, Outcomes of referral to dermatology for suspicious lesions, Arch Dermatol, 147, 556, 10.1001/archdermatol.2011.108